Investigational Site Number 643009

Moscow 127486

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Hematopoietic Neoplasm, Neuropathic Pain, Relapsing-remitting Multiple Sclerosis

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 — Stopped early
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain — Completed